Home
Contact Careers rss
 

WHO and UNAIDS Welcome Ground Breaking Proof Of Concept Study Results For Vaginal Gel Showing Reduced Risk of HIV Infections In Women

WHO and UNAIDS congratulate CAPRISA, a designated UNAIDS Collaborating Centre for HIV Prevention Research, on the successful completion of the study.  The full statement is available here: http://www.unaids.org/en/KnowledgeCentre/Resources/PressCentre/PressReleases/2010/20100719_PS.asp.

Follow Us:
Follow us on Facebook     Follow us on Twitter     Follow us using LinkedIn

Global HIV Vaccine Enterprise, 200 Park Ave. S. Suite 1501, New York, NY 10003 | +1 212-461-3692 or toll free at +1-866-966-4483

All Content ©2005 - 2010 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account